Paper39267014
Curcumin suppresses colorectal tumorigenesis through restoring the gut microbiota and metabolites.
Deng W and 6 others. BMC Cancer, 2024. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Curcumin suppresses colorectal tumorigenesis through restoring the gut microbiota and metabolites. Papers, record 39267014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39267014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Curcumin suppresses colorectal tumorigenesis through restoring the gut microbiota and metabolites.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gastrointestinal Microbiome | Major topic |
| Curcumin | Major topic |
| Colorectal Neoplasms | Major topic |
| Mice, Inbred C57BL | Major topic |
| Animals | |
| Mice | |
| Male | |
| Disease Models, Animal | |
| Azoxymethane | |
| Carcinogenesis | |
| Dextran Sulfate | |
| RNA, Ribosomal, 16S | |
| Metabolomics | |
| Humans |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 20232BAB206163 | the Natural Science Foundation of Jiangxi Province | PubMed | ||
| No. GJJ160112 | the Science and Technology Research Project of Jiangxi Provincial Education Department | PubMed | ||
| 32260168 | the National Natural Science Foundation of China | PubMed |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34937766 | Lactobacillus gallinarum modulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis. | Gut | 2021 | https://conductscience.org/library/papers/34937766 | PubMed |
| 2 | 31631858 | Colorectal cancer. | Lancet | 2019 | https://conductscience.org/library/papers/31631858 | PubMed |
| 3 | 31132111 | Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial. | J Nutr | 2019 | https://conductscience.org/library/papers/31132111 | PubMed |
| 4 | 35952517 | Natural shikonin and acetyl-shikonin improve intestinal microbial and protein composition to alleviate colitis-associated colorectal cancer. | Int Immunopharmacol | 2022 | https://conductscience.org/library/papers/35952517 | PubMed |
| 5 | 35565884 | Lactiplantibacillus plantarum-12 Alleviates Inflammation and Colon Cancer Symptoms in AOM/DSS-Treated Mice through Modulating the Intestinal Microbiome and Metabolome. | Nutrients | 2022 | https://conductscience.org/library/papers/35565884 | PubMed |
| 6 | 36291546 | Curcumin Targeting Non-Coding RNAs in Colorectal Cancer: Therapeutic and Biomarker Implications. | Biomolecules | 2022 | https://conductscience.org/library/papers/36291546 | PubMed |
| 7 | 34745023 | The Capacity to Produce Hydrogen Sulfide (H2S) via Cysteine Degradation Is Ubiquitous in the Human Gut Microbiome. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34745023 | PubMed |
| 8 | 35054828 | Curcumin and Weight Loss: Does It Work? | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35054828 | PubMed |
| 9 | 28823860 | Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice. | Gastroenterology | 2017 | https://conductscience.org/library/papers/28823860 | PubMed |
| 10 | 10658641 | Specific glutathione binding sites in pig cerebral cortical synaptic membranes. | Neuroscience | 2000 | https://conductscience.org/library/papers/10658641 | PubMed |
| 11 | 1912370 | Review of ubenimex (Bestatin): clinical research. | Biomed Pharmacother | 1991 | https://conductscience.org/library/papers/1912370 | PubMed |
| 12 | 2379282 | Studies on the antitumor-promoting activity of naturally occurring substances. II. Inhibition of tumor-promoter-enhanced phospholipid metabolism by umbelliferous materials. | Chem Pharm Bull (Tokyo) | 1990 | https://conductscience.org/library/papers/2379282 | PubMed |
| 13 | 37169888 | Gut microbiota in colorectal cancer development and therapy. | Nat Rev Clin Oncol | 2023 | https://conductscience.org/library/papers/37169888 | PubMed |
| 14 | 30741424 | Antitumor effects of curcumin: A lipid perspective. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30741424 | PubMed |
| 15 | 37210578 | Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis. | Cell Death Differ | 2023 | https://conductscience.org/library/papers/37210578 | PubMed |
| 16 | 12226327 | Biosynthesis of Caffeine in Leaves of Coffee. | Plant Physiol | 1996 | https://conductscience.org/library/papers/12226327 | PubMed |
| 17 | 6433972 | Dismutation of dihydrofolate by dihydrofolate reductase. | Biochemistry | 1984 | https://conductscience.org/library/papers/6433972 | PubMed |
| 18 | 34843863 | Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation? | Cancer Lett | 2022 | https://conductscience.org/library/papers/34843863 | PubMed |
| 19 | 37482657 | Colorectal cancer and gut microbiota studies in China. | Gut Microbes | 2023 | https://conductscience.org/library/papers/37482657 | PubMed |
| 20 | 32907806 | Performance and Application of 16S rRNA Gene Cycle Sequencing for Routine Identification of Bacteria in the Clinical Microbiology Laboratory. | Clin Microbiol Rev | 2020 | https://conductscience.org/library/papers/32907806 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42919975 | NRF2 modulation in colorectal cancer chemoprevention: integrating traditional medicine with translational strategies against oxidative stress, inflammation, and cancer stem cells. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42919975 | PubMed |
| 42884079 | Targeting the Microbiota-Metabolism-Immunity Axis: Active Components of Traditional Chinese Medicine in Colitis-Associated Colorectal Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42884079 | PubMed |
| 42828152 | Progress on the regulation of colorectal cancer and cardio-oncology by the gut microbiota and nutrients. | Front Immunol | 2026 | https://conductscience.org/library/papers/42828152 | PubMed |
| 42821123 | Modulation of the gut microbiota by traditional Chinese medicine to attenuate chemotherapy-induced toxicity in gastric cancer: a review. | Support Care Cancer | 2026 | https://conductscience.org/library/papers/42821123 | PubMed |
| 42434566 | Effects of micronized bamboo powder on performance, nutrient utilization, intestinal histology, and cecal microbiota in laying hens. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42434566 | PubMed |
| 42298579 | The nutrigenomic-epigenetic axis in cancer: from dietary bioactives to precision oncology. | Nutr Metab (Lond) | 2026 | https://conductscience.org/library/papers/42298579 | PubMed |
| 42278572 | A Systematic Review of Folate and the Human Enteric Microbiome: Biological Mechanisms and Clinical Implications. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278572 | PubMed |
| 42197095 | Curcumin and Cancer-Related Inflammation. | Nutrients | 2026 | https://conductscience.org/library/papers/42197095 | PubMed |
| 42153622 | Oral Lactobacillus reuteri Combined With Intravenous Lysis-Circuit-Bearing Engineered Bacteria RE Enhances Antitumor Efficacy. | Biotechnol J | 2026 | https://conductscience.org/library/papers/42153622 | PubMed |
| 42006709 | Plant-bacteria hybrid nanovesicles for targeted sonodynamic therapy: A microbiome-friendly precision strike against H. pylori infections. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42006709 | PubMed |
| 41870804 | Advances of curcumin-loaded hydrogels for multimodal cancer therapeutics. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41870804 | PubMed |
| 41692806 | ZSGSD inhibits colorectal cancer via PI3K/AKT/mTOR pathway: pharmacological and experimental evidence. | Hereditas | 2026 | https://conductscience.org/library/papers/41692806 | PubMed |
| 41515171 | Curcumin Rewires the Tumor Metabolic Landscape: Mechanisms and Clinical Prospects. | Nutrients | 2025 | https://conductscience.org/library/papers/41515171 | PubMed |
| 41305617 | Modulating Strategies of the Intestinal Microbiota in Colorectal Cancer. | Nutrients | 2025 | https://conductscience.org/library/papers/41305617 | PubMed |
| 41299217 | Multi-omics reveals the impact of Clonorchis sinensis infection on mouse gut microbiota, metabolomics and transcriptomics. | BMC Microbiol | 2025 | https://conductscience.org/library/papers/41299217 | PubMed |
| 41195234 | Interplay Between Dietary Phytochemicals and Gut Microbiota in Colorectal Cancer: Future Directions and Considerations. | J Nutr Metab | 2025 | https://conductscience.org/library/papers/41195234 | PubMed |
| 41104886 | Therapeutic potentials of plant‑based antioxidants on colorectal cancer: Challenges and perspectives (Review). | Int J Oncol | 2025 | https://conductscience.org/library/papers/41104886 | PubMed |
| 41089849 | Curcumin in colorectal cancer: mechanistic insights, pharmacological limitations, and translational perspectives. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41089849 | PubMed |
| 41002416 | Curcumin Inhibits Protease Activated Receptor 2-Induced ERK Phosphorylation Calcium Mobilization and Anti-Apoptotic Signaling in Inflammation-Driven Colorectal Cancer Cells. | Cells | 2025 | https://conductscience.org/library/papers/41002416 | PubMed |
| 41001347 | Mechanisms and advantages of natural derived small molecule compounds in the prevention and treatment of colorectal cancer: a review. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41001347 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39267014
GET https://conductscience.org/api/papers/v1/39267014/references?page=2